Clinical trials
Active, not recruiting Prostatic Neoplasms trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2020 | 5 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 2 |
| Amgen | 1 |
| Aragon Pharmaceuticals, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bayer | 1 |
| Celgene | 1 |
| Exelixis | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 18 |
| Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
| Prostatic Neoplasms, Castration-Resistant | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.